Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

It's a brand-new year, and with that comes a tonne of new music for your lugholes. Let's see what the first New Music Friday of 2026 has to offer, shall we? Global girl group KATSEYE kick off the New ...

Abstract: Influence maximization in social networks has become a popular research area, aiming to identify the best set of nodes to spread information or influence within a network. Traditional ...

Abstract: Holographic Multiple-Input Multiple-Output (HMIMO), which densely integrates numerous antennas into a limited space, is anticipated to provide higher rates for future 6G wireless ...